Remarkable effect of milnacipran in the treatment of Japanese major depressive patients
β Scribed by Hisashi Higuchi; Keizo Yoshida; Hitoshi Takahashi; Shingo Naito; Kei Tsukamoto; Mitsuhiro Kamata; Kenichi Ito; Kazuhiro Sato; Tetsuo Shimizu
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 35 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.392
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Modern community-based studies have revealed high prevalence rates for major depression in adults. Despite this high prevalence, many depressed individuals do not seek treatment and only a minority of those that do are prescribed antidepressants. This paper considers the role of antidepressants, esp
## Abstract The effects of milnacipran (50βmg bid) on sleep patterns of eight depressed inpatients, treated for 4 weeks, were studied during the initial (days 1β3) and terminal (days 26β28) treatment periods and compared with those obtained from three sleep recordings performed just prior to the in
## Abstract ## Introduction Bupropion immediate release (IR) and bupropion sustained release (SR) are frequently used to treat geriatric depression, as they have few cardiovascular, gastrointestinal and sexual adverse effects. We sought to examine the efficacy and dosing patterns of bupropion in a
It has been suggested that weight change might be associated with certain neuroendocrine abnormalities often observed in patients suering from a depressive illness. This preliminary study examined whether objective measures of weight change were associated with dexamethasone suppression test (DST) r